Graybug Vision Inc (GRAY) News
Filter GRAY News Items
GRAY News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
GRAY News Highlights
- GRAY's 30 day story count now stands at 2.
- Over the past 16 days, the trend for GRAY's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
- The most mentioned tickers in articles about GRAY are STAR.
Latest GRAY News From Around the Web
Below are the latest news stories about Graybug Vision Inc that investors may wish to consider to help them evaluate GRAY as an investment opportunity.
Graybug Vision (GRAY) Receives a Hold from Leerink PartnersLeerink Partners analyst Marc Goodman maintained a Hold rating on Graybug Vision (GRAY – Research Report) on December 17 and set a price target of $5.00. The company's shares closed last Wednesday at $2.06, close to its 52-week low of $1.79. According to TipRanks.com, Goodman is a 2-star analyst with an average return of 0.1% and a 42.5% success rate. Goodman covers the Healthcare sector, focusing on stocks such as Biohaven Pharmaceutical Holding Co, Intra-Cellular Therapies, and Satsuma Pharmaceuticals. Graybug Vision has an analyst consensus of Hold, with a price target consensus of $4.00, which is a 99.0% upside from current levels. |
We Think Graybug Vision (NASDAQ:GRAY) Needs To Drive Business Growth CarefullyJust because a business does not make any money, does not mean that the stock will go down. For example, although... |
Graybug Vision, Inc. (NASDAQ:GRAY) Stake Trimmed by Geode Capital Management LLCGeode Capital Management LLC cut its holdings in shares of Graybug Vision, Inc. (NASDAQ:GRAY) by 43.0% in the second quarter, HoldingsChannel reports. The fund owned 70,382 shares of the companys stock after selling 52,989 shares during the quarter. Geode Capital Management LLCs holdings in Graybug Vision were worth $382,000 as of its most recent SEC [] |
Graybug Vision, Inc. (NASDAQ:GRAY) Stock Position Lifted by Vanguard Group Inc.Vanguard Group Inc. lifted its holdings in Graybug Vision, Inc. (NASDAQ:GRAY) by 80.2% in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 430,387 shares of the companys stock after purchasing an additional 191,568 shares during the quarter. Vanguard Group Inc. owned 2.04% of Graybug [] |
Graybug Vision, Inc. to Post FY2021 Earnings of ($1.64) Per Share, Wedbush Forecasts (NASDAQ:GRAY)Graybug Vision, Inc. (NASDAQ:GRAY) – Investment analysts at Wedbush cut their FY2021 earnings per share (EPS) estimates for Graybug Vision in a report issued on Monday, November 15th. Wedbush analyst L. Moussatos now forecasts that the company will post earnings per share of ($1.64) for the year, down from their prior forecast of ($1.57). Wedbush […] |
Graybug Vision to Participate in the Piper Sandler 33rd Annual Virtual Healthcare ConferenceBALTIMORE, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmaceutical company focused on developing transformative medicines for the treatment of diseases of the retina and optic nerve, today announced that Fred Guerard, PharmD, Chief Executive Officer of Graybug Vision, will participate in a pre-recorded fireside chat at the Piper Sandler 33rd Annual Virtual Healthcare Conference, which will be available on the conference website beginning at 10 a.m. ET / 7 a.m. PT on November 22, 2021. |
Graybug Vision to Participate in the Piper Sandler 33rd Annual Virtual Healthcare ConferenceBALTIMORE, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmaceutical company focused on developing transformative medicines for the treatment of diseases of the retina and optic nerve, today announced that Fred Guerard, PharmD, Chief Executive Officer of Graybug Vision, will participate in a pre-recorded fireside chat at the Piper Sandler 33rd Annual Virtual Healthcare Conference, which will be available on the conference website beginning at 10 a. |
Graybug Vision (NASDAQ:GRAY) Posts Quarterly Earnings Results, Misses Expectations By $0.01 EPSGraybug Vision (NASDAQ:GRAY) announced its earnings results on Thursday. The company reported ($0.38) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.37) by ($0.01), MarketWatch Earnings reports. Shares of NASDAQ:GRAY opened at $3.14 on Friday. The company has a 50-day moving average price of $3.43 and a two-hundred day moving average price [] |
Global Ocular Drug Delivery Devices Market to 2027: Leading Players Include Novartis, Allergan, Graybug Vision and Envisia TherapeuticsDUBLIN, Nov. 12, 2021 /PRNewswire/ -- The "Ocular Drug Delivery Devices Market" report has been added to ResearchAndMarkets.com''s offering. The global ocular drug delivery devices market is expected to grow at a CAGR of around 5.3% during 2021-2027. This report on global ocular drug |
Graybug Vision Announces Financial Results for the Three and Nine Months Ended September 30, 2021, and Recent Corporate DevelopmentsBALTIMORE, Nov. 11, 2021 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmaceutical company focused on developing transformative medicines for the treatment of diseases of the retina and optic nerve, today provided an update on recent corporate developments and reported financial results for the three and nine months ended September 30, 2021. |